These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 30518830)

  • 21. Crucial role of T cells in NAFLD-related disease: A review and prospect.
    Mao T; Yang R; Luo Y; He K
    Front Endocrinol (Lausanne); 2022; 13():1051076. PubMed ID: 36457551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
    Qi X; Lai J
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.
    Muir K; Hazim A; He Y; Peyressatre M; Kim DY; Song X; Beretta L
    Cancer Res; 2013 Aug; 73(15):4722-31. PubMed ID: 23749645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.
    Yu Y; Shi X; Zheng Q; Wang X; Liu X; Tan M; Lv G; Zhang P; Martin RC; Li Y
    Int J Biol Sci; 2021; 17(10):2576-2589. PubMed ID: 34326695
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
    Dongiovanni P; Romeo S; Valenti L
    World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease.
    Ramanathan R; Ali AH; Ibdah JA
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease.
    Puengel T; Liu H; Guillot A; Heymann F; Tacke F; Peiseler M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.
    Branković M; Jovanović I; Dukić M; Radonjić T; Oprić S; Klašnja S; Zdravković M
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
    Fontes A; Alemany-Pagès M; Oliveira PJ; Ramalho-Santos J; Zischka H; Azul AM
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
    Torres DM; Harrison SA
    Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent updates on targeting the molecular mediators of NAFLD.
    Wang J; Wang L; Zhang XJ; Zhang P; Cai J; She ZG; Li H
    J Mol Med (Berl); 2023 Feb; 101(1-2):101-124. PubMed ID: 36792729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling.
    Liang JQ; Teoh N; Xu L; Pok S; Li X; Chu ESH; Chiu J; Dong L; Arfianti E; Haigh WG; Yeh MM; Ioannou GN; Sung JJY; Farrell G; Yu J
    Nat Commun; 2018 Oct; 9(1):4490. PubMed ID: 30367044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
    Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update.
    Hliwa A; Ramos-Molina B; Laski D; Mika A; Sledzinski T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.
    Kim H; Lee DS; An TH; Park HJ; Kim WK; Bae KH; Oh KJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.